Fiji vs Turkmenistan: New cases tested for RR-/MDR-TB
Fiji
100.0%
in 2024
Turkmenistan
100.0%
in 2022
Fiji rank
1st
Turkmenistan rank
1st
New cases tested for RR-/MDR-TB over time
- Fiji
- Turkmenistan
How they compare
Fiji currently reports 100.0% against 100.0% in Turkmenistan, a difference of 0.0%.
The two have swapped places 1 time across 8 shared years of data; in 2006 it was Fiji ahead.
Fiji ranks 1st and Turkmenistan ranks 1st of 192 countries.
Across the 3 decades both report, Fiji averaged higher in 1 and Turkmenistan in 2.
Head to head by decade
| Decade | Fiji | Turkmenistan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 29.5% | 6.0% | 23.5% | Fiji |
| 2010s | 38.5% | 45.0% | 6.5% | Turkmenistan |
| 2020s | 65.3% | 100.0% | 34.7% | Turkmenistan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new cases tested for rr-/mdr-tb, Fiji or Turkmenistan?
- Fiji, at 100.0% against 100.0% in Turkmenistan as of 2024.
- What is the difference in new cases tested for rr-/mdr-tb between Fiji and Turkmenistan?
- 0.0%, with Fiji ahead.
- How many years of comparable data are there for Fiji and Turkmenistan?
- 8 years are reported by both, from 2006 to 2022.
- How do Fiji and Turkmenistan rank globally for new cases tested for rr-/mdr-tb?
- Fiji ranks 1st and Turkmenistan ranks 1st of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.